Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 2 Trial Data Published in the New England Journal of Medicine, the Phase 2 randomized controlled trial enrolled adults with obesity (body mass index 30) or overweight with weight-related comorbidities
Trial populations and endpoints vary, and individual outcomes differ
Previous research from the University of Utah Health has shown that using the popular GLP-1 medication Ozempic decreased lean mass or muscle mass without fat by around 10 percent, although some estimates show as much as 40 percent
One documented 9-week protocol showed deadlift and squat performance holding steady throughout, though this was at lower doses (0.5-1mg)
There are no co-nutrients and absorption is standard, making it ideal for basic supplementation
US$ 23.46
US$ 23.11
US$ 27.37
